10-K Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001564590-14-005961`
Period End Date	20140930
Filing Date	20141125
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	arwr-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 89 Income Statement 112 Cash Flow Statement 137 Stockholders Equity 40

Balance Sheet 89 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Trade receivable	`AccountsReceivableNetCurrent`	$75.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	18,300.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	9,900.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	9,900.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$588.63K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	18,300.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$532.35K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.50K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$91.66K	USD	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$21.65M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$9.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$28.84M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$154.80M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.66M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.49M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.78M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.01M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.24M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$1.70M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$23.09M	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$30.01K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$37.33M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$182.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.58M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.20M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$638.88K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$905.77K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.10M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.17M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$221.34K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.99K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$971.56K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$588.34K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$58.49K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$8.73M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$11.85M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$50.00K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$1.06M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$758.34K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$173.62K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$1.60M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$255.21K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$163.44K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$2.87M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.98M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 18,300 and 9,900 shares issued and outstanding as of September 30, 2014 and September 30, 2013, respectively	`PreferredStockValue`	$18.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 18,300 and 9,900 shares issued and outstanding as of September 30, 2014 and September 30, 2013, respectively	`PreferredStockValue`	$10.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 54,656,936 and 32,489,444 shares issued and outstanding as of September 30, 2014 and September 30, 2013, respectively	`CommonStockValue`	$124.86K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 54,656,936 and 32,489,444 shares issued and outstanding as of September 30, 2014 and September 30, 2013, respectively	`CommonStockValue`	$147.03K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$193.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$391.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-224.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.14M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$166.54M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$27.50M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-1.76M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$37.33M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$182.82M	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$159.02K	USD	1 Quarter
REVENUE	`Revenues`	$146.88K	USD	Annual
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$290.27K	USD	Annual
REVENUE	`Revenues`	$175.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.71M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$23.14M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.39M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$6.67M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$12.83M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$6.41M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.44M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.49M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.89M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$5.70M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.24M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.54M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	Annual
Impairment expense	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.31M	USD	Annual
Impairment expense	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$2.17M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.42M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.38M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$53.45M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$24.88M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$21.24M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-24.59M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-12.70M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-22.35M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-8.00M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-53.28M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-6.39M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-4.81M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-5.39M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-21.09M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-11.21M	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-240.15K	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-78.87K	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-641.14K	USD	Annual
Impairment on investment in unconsolidated affiliates	`ImpairmentOfInvestments`	$1.64M	USD	Annual
Gain on purchase of Roche Madison	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$1.58M	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.08M	USD	Annual
Realized and unrealized gain (loss) in marketable securities	`MarketableSecuritiesGainLoss`	$-58.09K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$-97.91K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$645.49K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$35.97K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.03M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$386.89K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.30M	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-997.98K	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$82.09K	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-1.02M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-7.11M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-5.44M	USD	Annual
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-58.72M	USD	Annual
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.11M	USD	Annual
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.70M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.30K	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-31.70M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-58.73M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-22.11M	USD	Annual
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-354.00	USD	Annual
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-80.00	USD	Annual
NET LOSS	`ProfitLoss`	$-58.73M	USD	Annual
NET LOSS	`ProfitLoss`	$-13.81M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-11.63M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-10.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-31.70M	USD	Annual
NET LOSS	`ProfitLoss`	$-6.94M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-22.43M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-4.78M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-22.11M	USD	Annual
NET LOSS	`ProfitLoss`	$-13.98M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-6.18M	USD	1 Quarter
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-984.79K	USD	Annual
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-560.14K	USD	Annual
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.22K	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-31.14M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-58.63M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-4.61M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.69M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.76M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-21.13M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.43M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.08M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-1.25	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-1.90	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-1.30	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	46.93M	shares	Annual
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.00M	shares	Annual
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.13M	shares	Annual

Cash Flow Statement 137 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-13.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-31.70M	USD	Annual
Net loss	`ProfitLoss`	$-6.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.78M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.11M	USD	Annual
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.18M	USD	1 Quarter
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-984.79K	USD	Annual
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-560.14K	USD	Annual
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.22K	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-31.14M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-58.63M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-4.61M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.69M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.76M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-21.13M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.43M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.08M	USD	1 Quarter
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-354.00	USD	Annual
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-80.00	USD	Annual
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$-58.09K	USD	Annual
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.49M	shares	Point-in-time
Charge for bad debt allowance	`ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances`	$2.50M	USD	Annual
(Gain) loss on purchase of Roche Madison	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$1.58M	USD	Annual
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	Annual
Common stock value	`CommonStockValue`	$124.86K	USD	Point-in-time
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	Annual
Common stock value	`CommonStockValue`	$147.03K	USD	Point-in-time
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.08M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.03M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$386.89K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.30M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.42M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.38M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$5.70M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.24M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.54M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	Annual
Amortization/accretion of note premiums/discounts, net	`AmortizationOfDebtDiscountPremium`	$793.89K	USD	Annual
Amortization/accretion of note premiums/discounts, net	`AmortizationOfDebtDiscountPremium`	$128.41K	USD	Annual
Amortization/accretion of note premiums/discounts, net	`AmortizationOfDebtDiscountPremium`	$9.39K	USD	Annual
Gain on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-84.72K	USD	Annual
Non-cash gain in equity investment	`NonCashGainInEquityInvestment`	$87.20K	USD	Annual
Non-cash impairment expense	`NonCashImpairmentCharges`	$1.64M	USD	Annual
Non-cash impairment expense	`NonCashImpairmentCharges`	$2.32M	USD	Annual
Non-cash impairment expense	`NonCashImpairmentCharges`	$2.17M	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-240.15K	USD	Annual
Non-controlling interest	`NoncontrollingInterest`	$984.79K	USD	Annual
Non-controlling interest	`NoncontrollingInterest`	$560.14K	USD	Annual
Non-controlling interest	`NoncontrollingInterest`	$95.22K	USD	Annual
Receivables	`IncreaseDecreaseInAccountsReceivable`	$-75.00K	USD	Annual
Receivables	`IncreaseDecreaseInAccountsReceivable`	$65.62K	USD	Annual
Receivables	`IncreaseDecreaseInAccountsReceivable`	$-162.85K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$25.87K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$938.18K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.08K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$15.81K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$338.53K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-44.71K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$30.60K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$13.29K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.81K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$291.88K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$321.65K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.41M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.48M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$186.37K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$27.92K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-187.91K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$94.26K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$882.30K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-19.03M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.42M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-15.34M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.72M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$479.71K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$296.88K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$10.00K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$89.50K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$290.31K	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.73M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.37M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.42M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$11.59M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$509.01K	USD	Annual
Cash transferred in acquisitions/divestitures	`CashDivestedFromDeconsolidation`	$-121.03K	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$440.64K	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-36.48M	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.52M	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$214.80K	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$225.41K	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$196.61K	USD	Annual
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$172.64M	USD	Annual
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$42.45M	USD	Annual
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$36.00M	USD	Point-in-time
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$10.88M	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$74.24K	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$12.88M	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$2.06M	USD	Annual
Proceeds from sale of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$8.00K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.77M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$44.29M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$185.29M	USD	Annual
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-354.00	USD	Annual
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-280.00	USD	Annual
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	Annual
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	Annual
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	Annual
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-280.00	USD	Annual
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-354.00	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.13M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.74M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$113.40M	USD	Annual
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Interest paid	`InterestPaid`	$25.64K	USD	Annual
Interest paid	`InterestPaid`	$42.04K	USD	Annual
Interest paid	`InterestPaid`	$42.27K	USD	Annual

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
Exercise of warrants, Amount	`WarrantsExercisedDuringPeriodValue`	$50.41K	USD	Annual
Exercise of warrants, Amount	`WarrantsExercisedDuringPeriodValue`	$2.05M	USD	Annual
Exercise of warrants, Amount	`WarrantsExercisedDuringPeriodValue`	$10.15M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.73M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$23.83K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.58K	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	675.00	shares	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	454,863.00	shares	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.54M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.24M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.70M	USD	Annual
Subscription payment	`SubscriptionReceivable`	$16.00K	USD	Annual
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	1.67M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	1.83M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	3.07M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	2.26M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Fractional shares redeemed in reverse stock split	`StockIssuedDuringPeriodSharesReverseStockSplits`	0.00	shares	Point-in-time
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-13.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-31.70M	USD	Annual
Net loss	`ProfitLoss`	$-6.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.78M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.11M	USD	Annual
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.18M	USD	1 Quarter
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
Establish and settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$5.96M	USD	Annual
Establish and settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$1.60M	USD	Annual
Deconsolidation of Calando Pharmaceuticals, Inc.	`NoncontrollingInterestDecreaseFromDeconsolidation`	$1.30M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.